RAPT Therapeutics (RAPT) EPS (Basic): 2020-2023
Historic EPS (Basic) for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to -$0.81.
- Therapeutics' EPS (Basic) fell 24.62% to -$0.81 in Q4 2023 from the same period last year, while for Dec 2023 it was -$3.05, marking a year-over-year decrease of 17.76%. This contributed to the annual value of -$3.05 for FY2023, which is 18.22% down from last year.
- As of Q4 2023, Therapeutics' EPS (Basic) stood at -$0.81, which was up 1.22% from -$0.82 recorded in Q3 2023.
- In the past 5 years, Therapeutics' EPS (Basic) registered a high of -$0.51 during Q2 2020, and its lowest value of -$0.82 during Q3 2023.
- Moreover, its 3-year median value for EPS (Basic) was -$0.66 (2022), whereas its average is -$0.68.
- In the last 5 years, Therapeutics' EPS (Basic) increased by 1.59% in 2022 and then slumped by 30.16% in 2023.
- Quarterly analysis of 4 years shows Therapeutics' EPS (Basic) stood at -$0.52 in 2020, then fell by 17.31% to -$0.61 in 2021, then declined by 6.56% to -$0.65 in 2022, then declined by 24.62% to -$0.81 in 2023.
- Its last three reported values are -$0.81 in Q4 2023, -$0.82 for Q3 2023, and -$0.66 during Q2 2023.